DEBN
@debn.eu
We are urological start-up focused on the reduction of infectious complications following #prostatebiopsy by #DEBN - Drug-Eluting Biopsy Needle (WO2016118026)
DEBN's Company Logos
DEBN's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#297BC2
Mariner
41, 123, 194
208, 65, 46
79, 37, 0, 24
#FB2C4A
Radical Red
251, 44, 74
351, 96, 58
0, 82, 71, 2
#0C0D2C
Haiti
12, 13, 44
238, 57, 11
73, 70, 0, 83
About DEBN
DEBN is a brand that offers a groundbreaking solution to the problem of infectious complications associated with transrectal ultrasound guided prostate biopsy. Prostate cancer affects 1 in 6 men globally and is the most common cancer among men in developed countries, leading to premature death and various health issues. The traditional biopsy procedure exposes patients to serious infections and poses high risks for both urologists and healthcare systems.
DEBN's drug-eluting biopsy needles kit is a game-changer in this field. The kit consists of polymer-coated biopsy and anesthesia needles that release an effective antibiotic combination directly into the prostate during the procedure. This innovative approach broadens the spectrum of antibiotics' activity, potentially reducing the number of complications.
DEBN is the first medical device to enable simultaneous organ-targeted antibiotic delivery during a prostate biopsy. It has been confirmed by the European Patent Office as a novel, inventive, and industrially applicable solution. DEBN's team, comprised of expert doctors and urologists, is dedicated to improving this groundbreaking technology.
Contact DEBN now to learn more about how this medical device can transform the safety and effectiveness of prostate biopsies
